Binding Characteristics of Anticancer Drug Doxorubicin with Two-Dimensional Graphene and Graphene Oxide: Insights from Density Functional Theory Calculations and Fluorescence SpectroscopyShow others and affiliations
2018 (English)In: The Journal of Physical Chemistry C, ISSN 1932-7447, E-ISSN 1932-7455, Vol. 122, no 36, p. 21031-21038Article in journal (Refereed) Published
Abstract [en]
There has been a perpetual interest in identifying suitable nano-carriers for drug delivery. In this regard, graphene-based two-dimensional materials have been proposed and demonstrated as drug carriers. In this paper, we have investigated the adsorption characteristics of a widely used anticancer drug, doxorubicin (DOX), on graphene (G) and graphene oxide (GO) by density functional theory calculations and fluorescence and X-ray photoelectron spectroscopies. From the calculated structural and electronic properties, we have concluded that G is a better binder of DOX compared to GO, which is also supported by our fluorescence measurements. The binding of DOX to G is mainly based on strong pi-pi stacking interactions. Consistent with this result, we also found that the sp(2) regions of GO interact with DOX stronger than the sp(3) regions attached with the functional groups; the binding is characterized by pi-pi and hydrogen-bonding interactions, respectively.
Place, publisher, year, edition, pages
AMER CHEMICAL SOC , 2018. Vol. 122, no 36, p. 21031-21038
National Category
Physical Chemistry
Identifiers
URN: urn:nbn:se:uu:diva-366741DOI: 10.1021/acs.jpcc.8b04496ISI: 000444920900049OAI: oai:DiVA.org:uu-366741DiVA, id: diva2:1269398
Funder
Swedish Research Council, 2016-05366Swedish Research Council, 20144423Swedish Research Council, 2017-05447Knut and Alice Wallenberg Foundation, KAW 2017.00552018-12-102018-12-102019-05-17Bibliographically approved